Budenofalk Uno 9 mg gastro-resistant granules
Milan Lukáš Orcid.org 1
+ Affiliation
To read this article in full, please register for free on this website.
Benefits for subscribers
Benefits for logged users
Literature
1. Souhrn údajů o přípravku. Budenofalk Uno 9 mg enterosolventní granule, Sp. zn. sukls82708 2014.
2. Dignass A, Stoynoiv S, Dorofeyev AE et al. Once versus three times daily dosing of oral budesonide for active Crohn’s disease: a double-blind, double-dummy, randomised trial. J Crohns Colitis 2014; 8 (9): 970–980. doi: 10.1016/j.crohns. 2014. 01.021.
3. Miehlke S, Madisch A, Kupcinskas L et al. Budesonide is more effective than mesalamine or placebo in short-term treatment of collagenous colitis. Gastroenterology 2014; 146 (5): 1222–1230. doi: 10.1053/j.gastro.2014.01.019.